Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 to reflect a newer site version.SummaryDifference0.0%

- Check26 days agoChange DetectedAdded a new 2024 publication citation for Long-Term Safety of Gantenerumab in Alzheimer’s disease to the study's Publications list, listing authors Neve A et al. with the DOI; the revision tag was updated to v3.6.2.SummaryDifference0.0%

- Check41 days agoChange DetectedRecruitment status has been updated to closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The removal of the old 'Intervention / Treatment' heading and the update to the site revision banner (v3.6.0) reflect a reorganization and version update.SummaryDifference0.2%

- Check48 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects an update to the page’s versioning rather than changes to the study content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.SummaryDifference0.0%

- Check83 days agoChange DetectedThe Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.